✨
AI Summary
- FDA updates leucovorin labeling, leading GSK to re-withdraw its application.
- Evaluating Steve Ubl's tenure as PhRMA president and CEO.
- Discussing potential qualities sought in PhRMA's next leader.
Guests on This Episode
BS
Bridget Silverman
4 podcast appearances
NH
Nielsen Hobbs
8 podcast appearances